Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of JNJ-77242113 (Icotrokinra) in biologic-naïve participants with active psoriatic arthritis is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Icotrokinra (JNJ-77242113) (JNJ-77242113)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING